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We analyzed the metal-binding properties of human centrin-2 (HsCen-2) and followed the
changes in HsCen-2 structure upon metal-binding using micro-electrospray ionization mass
spectrometry (ESI-MS). Apo-HsCen-2 is mostly monomeric. The ESI spectra of HsCen-2
show two charge-state distributions, representing two conformations of the protein. HsCen-2
binds four moles calcium/mol protein: one mol of calcium with high affinity, one additional
mol of calcium with lower affinity, and two moles of calcium at low affinity sites. HsCen-2
binds four moles of magnesium/mol protein. The conformation giving the lower charge-state
HsCen-2 by ESI, binds calcium and magnesium more readily than does the higher charge-state
HsCen-2. Both conformations of HsCen-2 bind calcium more readily than magnesium.
Calcium was more effective in displacing magnesium bound to HsCen-2 than vice versa.
Binding of a peptide from a known binding partner, the xeroderma pigmentosum comple-
mentation group protein C (XPC), to apo-HsCen-2, occurs in the presence or the absence of
calcium. Near and far-UV CD spectra of HsCen-2 show little difference with addition of
calcium or magnesium. Minor changes in secondary structure are noted. Melting curves
derived from temperature dependence of molar ellipticity at 222 nm for HsCen-2 show that
calcium increases protein stability whereas magnesium does not. 25 HsCen-2 behaves
similarly to HsCen-2. We conclude that HsCen-2 binds calcium and magnesium and that
calcium modulates HsCen-2 structure and function by increasing its stability without
undergoing significant changes in secondary or tertiary structure. (J Am Soc Mass Spectrom
2006, 17, 1158–1171) © 2006 American Society for Mass SpectrometryCentrins (or caltractins) are small (20 KDa),acidic EF-hand proteins that are important com-ponents of the centriole [1–5]. Centrin was first
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doi:10.1016/j.jasms.2006.04.029discovered in the flagellar apparatus of the green
alga, Tetraselmis striata, where it functions as a calci-
um-sensing regulator of centriole structure and func-
tion, and as part of the calcium-dependent contractile
apparatus [6]. Centrins have been identified in nu-
merous higher and lower organisms including fungi
(e.g., Dictyostelium), plants, and mammals, where
they function in centrosome duplication, localization,
and segregation [7]. Centrins control cilia-regulated
Ca2 channels [8], mammalian cilia function, and
could potentially play a role in the pathogenesis of
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sembly of a centrin-transducin complex in the verte-
brate visual system may regulate transducin translo-
cation through the photoreceptor connecting cilium
[10–12]. Centrins also play a role in microtubule
severing through interactions with Sfi1 [13, 14].
Centrin-2 (also known as caltractin-1), an important
component of the centriolar apparatus, is an EF-hand
protein that is essential for the function of the spindle
pole apparatus and centrosome duplication [5]. Centrin-2
is found in both cytoplasmic and nuclear compartments
and is a component of nearly all xeroderma pigmento-
sum (XP) nucleotide excision repair complexes, where it
binds and stabilizes the XPC protein [5, 15–18].
Full length human centrin-2 (HsCen-2), and the
carboxyl-terminal domains of HsCen-2 fragments, bind
calcium at one high affinity site, probably in the most
carboxyl-terminal EF-hand [19, 20]. Previous studies
suggested that HsCen-2 is dimeric and binds only two
calciums per dimer, likely to site IV in each monomer
[19]. Studies of an N-terminal 25 amino acid truncation
of HsCen-2 suggest that the N-terminus is involved in
the calcium-dependent dimerization of the protein [21].
On the other hand, Veeraraghavan et al. showed that
Chlamydomonas centrin-2 binds 4 mol of calcium/mol
protein [22].
Electrospray ionization mass spectrometry (ESI-MS)
has emerged as a powerful tool with which to study the
conformation, dynamics, and metal-binding properties
of proteins [23–40]. The mass measurement of intact
noncovalent complexes, for example, can be used to
determine ligand stoichiometry as well as relative affin-
ity constants [41, 42]. Furthermore, the charge-state
distributions of proteins seen in an ESI mass spectrum
contain information on the different conformers present
in solution under the conditions of the spray [43–45]. In
general, native conformers have charge-state distribu-
tions that are more narrow and at higher m/z than those
distributions of partially or fully unfolded conformers.
Thus, the parameters that affect protein conformation in
solution (e.g., pH, temperature, and solution composi-
tion) can be varied and the consequences measured by
ESI-MS. The changes in charge-state distributions mir-
ror the changes in solution of one conformer in the
presence of another.
In parallel with these applications, Kaltashov and
coworkers [46] advanced this approach by quantifying
conformation distributions using chemometrics. Their
approach deconvolved overlapping charge states to
afford the various conformer distributions in solution.
In addition to quantifying distributions, there is also an
opportunity to separate conformations (in terms of m/z)
and measure, for example, the binding property of one
conformer with respect to that of another. Ray and
coworkers [47] took this latter approach and demon-
strated that the native conformer of pfTIM binds more
ligand (ANS, a fluorescent dye) than the partially
unfolded conformers represented by higher charge
states.Considering the role HsCen-2 has in several impor-
tant biological functions and disease states, we wished
to take advantage of the sensitivity and speed of ESI-MS
to determine the properties of HsCen-2. Given that this
protein is conformationally flexible [19–21], we probed
if its flexibility might be manifest by multiple charge-
state distributions in its ESI mass spectrum. Addition-
ally, the ESI-MS approach would allow us to determine,
in a facile manner, the association of other proteins with
HsCen-2. We asked whether HsCen-2 exists in more
than one conformational state, and if so, whether the
calcium and magnesium-ion stoichiometry and affinity
were different for each conformer. We also investigated
whether the binding of calcium and magnesium are
associated with marked changes in the secondary struc-
ture, as revealed by optical spectroscopy, and in the
melting temperature of the protein.
Experimental
General
Protein amino-terminal and DNA sequencing were
carried out using automated methods as described
[48–53]. Oligonucleotide synthesis was performed us-
ing an Applied Biosystems DNA/oligonucleotide syn-
thesizer [54, 55] (Applied Biosystems, Foster City, CA).
UV spectra of proteins and nucleic acids were recorded
using a model DU-70 or DU-640 Beckman spectropho-
tometer (Beckman Instruments, Fullerton, CA). Protein
concentrations were determined by the BioRad Protein
Reagent (Bradford) method [56] (BioRad Laboratories,
Hercules, CA) and the BCA Reagent with bovine serum
albumin as standard (Pierce Biochemicals, Rockford, IL)
and by measuring UV absorbance using the millimolar
absorptivity of the HsCen-2 at 277 nm of EmM 1.46
mM1 cm1. SDS and non-denaturing PAGE were
carried out using a PhastGel apparatus (Amersham
Biosciences Corp., Piscataway, NJ) and precast gels.
Reagents were from Sigma (St. Louis, MO) unless
otherwise indicated.
Biosynthesis of Human Centrin-2 and 25 Human
Centrin-2 Proteins
Full-length HsCen-2 and 25 HsCen-2 proteins were
biosynthesized in E. coli BL21 cells, transformed with
pGEX-6P-1 plasmid (Amersham Biosciences Corp.) con-
taining the HsCen-2 cDNA sequence (GenBank acces-
sion NM_004344) using PCR and procedures described
previously [23, 24, 32, 57–60]. The purified full length
insert was ligated into BamHI- and XhoI-treated pGEX-
6P-1 plasmid. The 25 HsCen-2 sequence, derived from
PCR using a 5= primer with an additional PreScission
protease site incorporated, was inserted into the pCR2.1
TOPO vector (Invitrogen Corp., Carlsbad, CA). Plasmid
isolated from transformed E. coli TOP10 cells was
cleaved with EcoRI. The purified 25 HsCen-2 fragment
was ligated into EcoRI cut pGEX-6P-1 plasmid and used
1160 CRAIG ET AL. J Am Soc Mass Spectrom 2006, 17, 1158–1171to transform E. coli BL21 cells. Before expression, DNA
sequencing of both strands of final pGEX-6P-1 HsCen-2
constructs was carried out and the expected DNA
sequence for the constructs was verified. Transformed
E. coli BL21 cells with HsCen-2 and 25 HsCen-2
pGEX-6P-1 constructs were grown in 2XYT medium at
37 °C to an absorbance of 0.6 at 600 nm. Protein expres-
sion was induced with 1.0 mM isopropylthiogalactoside
at 37 °C. After 4 h, the cells were collected by centrifu-
gation at 4000  g and lysed in lysis buffer (PBS pH 7.0
with 5 mM EDTA, 5 mM DTT, 0.1 mM aminoethylben-
zene sulfonyl fluoride HCl (AEBSF) (Bio-Research
Products, Inc., North Liberty, IA) using 0.1-mm glass
beads and a Bead Beater (Biospec Products, Bartlesville,
OK). The clarified lysate was applied to a column of
glutathione-Sepharose resin (Clontech, Palo Alto, CA)
and washed with 50 mM Tris, 1 mM EDTA, 1 mM DTT,
pH 7.4 (WB). The fusion GST- HsCen-2 protein was
eluted in WB containing 20 mM glutathione (reduced),
concentrated to a few ml, and treated with PreScission
protease (Amersham Biosciences Corp.) at 4 °C. The
protease-treated protein was purified by chromatogra-
phy on a Mono-Q HR26/10 column (Amersham Bio-
sciences Corp.). A NaCl gradient (0-1 M NaCl; 1 L total
volume) was developed over 2 h. Mono-Q fractions
were assessed by Coomassie blue-stained SDS PAGE
gels and fractions containing pure HsCen-2 or 25
HsCen-2 were pooled, concentrated and dialyzed
against buffer (20 mM Tris, 1 mM DTT, 1 mM EDTA,
pH 7.4). This yielded, after PreScission protease cleav-
age, for full length HsCen-2 a construct with five amino
acids (GPLGS) added to the N-terminus derived from
the PreScission Protease cleavage site and the linker
region containing the pGEX-6P-1 BamHI site, and for
25 HsCen-2, a protein construct lacking the first 25
amino acids in HsCen-2, with two amino acids (GP)
added to the N-terminus, derived from the additional
PreScission protease recognition/cleavage sequence.
Protein Identification
Amino-terminal amino acid sequencing afforded
HsCen-2 construct sequences that were identical to the
sequences expected: for the full length HsCen-2 con-
structs: GPLGS followed by amino acids 1-40 of
HsCen-2; and for 25 HsCen-2, GP followed by amino
acids 26-35 of HsCen-2. Analysis of full-length Centrin
and 25 Centrin by ESI-MS afforded a multiply
charged ion series, which on transformation revealed a
single species of relative molecular mass of 20149 Da
(expected 20148Da) for the full length and a mass of
17,086 Da (expected 17084 Da) for the 25 human
centrin construct. This experimental value is well
within the 0.01% accuracy for such measurements.
Tryptic peptides derived from full length centrin were
analyzed by LC-MS/MS. A tryptic peptide map was
obtained covering 90% of the expected protein se-
quence. The biosynthetic proteins were thus unambig-
uously characterized by ESI-MS mass spectrometry,N-terminal sequencing, and by tryptic digestion and
peptide analysis by MS/MS to be the expected con-
structs of human centrin and 25 centrin.
XPC Peptide Synthesis and Preparation
The 17 amino acid human xeroderma pigmentosa
group C peptide (NWKLLAKGLLIRERLKR) Asn847-
Arg863 (XPC) [16] was synthesized in the Mayo Pro-
teomics Research Center Peptide Synthesis Facility. A
stock solution 1.54 mg/ml (730 M) (by weight) was
made by dissolving XPC peptide into 20 mM ammo-
nium acetate, 10 M EDTA (free acid) pH 6.9 and
subsequently used for ESI-MS measurements.
Microelectrospray Ionization Mass Spectrometry
(ESI-MS)
Before infusion into the ESI-MS apparatus, stock so-
lutions (72 M) of purified HsCen-2 or 25 HsCen-2
were prepared. Biosynthesized HsCen-2 or 25
HsCen-2 in 50 mM Tris, 1 mM sodium ethylene diamine
tetraacetic acid (Na EDTA), 1 mM DTT, pH 7.4, were
dialyzed extensively against 20 mM ammonium acetate,
10 M EDTA (free acid) pH 6.9 at 4 °C in a 10  0.5 ml
microdialyzer, 1000 MWCO SpectraPor 6 dialysis mem-
brane (Spectrum Industries, Rancho Dominguez, CA).
10 M EDTA was present to scavenge divalent cations
before metal titrations. Stock solutions were used for
ESI-MS as described below.
ESI-MS analyses of HsCen-2 and the metal ion
titration experiments were performed in positive mode
on a Micromass LCT mass spectrometer (Waters Corp.,
Milford, MA) using a modified Z-spray electrospray
source. The mass spectra were scanned from mass to
charge (m/z) 700–5000 at a scan speed of 1.9 s and
instrument resolution of 4000. Vacuum pressure and
sample cone, RF lens, and extraction cone voltages were
optimized for detection of noncovalent interactions.
Working solutions of 17 M or 52 M HsCen2 and
25 HsCen-2 were prepared using 25 mM ammonium
acetate, pH 7.5, from the 72 M stock solutions. Sam-
ples were introduced into the electrospray source by
direct infusion at a flow rate of 0.3 L/min. Metal ion
titration experiments were carried out by incubating
Hs-Cen2 with appropriate concentrations of metal salts
for 30 min. Stock solutions of metal ions as the acetate
salt were prepared in 25 mM ammonium acetate, pH
7.5. The final pH of the incubation solutions ranged
from 7.5 (no metals ions) to 7.4 (500 M metal ions). In
the competitive binding experiments, a secondary metal
salt was added after the 30 min incubation and allowed
to incubate for an additional 30 min before direct
infusion of samples into the ESI source. Xeroderma
pigmentosum group C peptide (XPC) was prepared as
described above. HsCen-2 and XPC incubates were
analyzed after 30 min, 6 h, and 72 h for the complexes.
Collected raw spectra from all analyses were trans-
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Waters Corp.).
Circular Dichroism Spectroscopy
CD spectra of HsCen-2 at protein concentration 0.1
mM were collected on a J-810 spectropolarimeter
(JASCO, Japan) continuously purged by N2 and
equipped with a temperature-control system CTC-345.
Spectral and temperature-dependent measurements
were performed using a U-type quartz cell of path
length 0.148 mm in the far-UV range (185–250 nm) at a
bandwidth of 2 nm, and a rectangular 0.5-cm cell in
near-UV range (250–320 nm) at bandwidth of 1 nm in a
custom-built thermostated cell holder. CD spectra were
recorded using five accumulations, each at scan speed
of 20 nm/min and a response time of 2 s. CD spectra
were collected at 0 °C. The continuous temperature
dependence of the ellipticity at 222 nm was measured
using a scan rate of 60 °C/h and a response time of 8 s.
Solvent evaporation was prevented by placing a drop of
oil (that had been repeatedly boiled in water to remove
soluble impurities) on the top of the sample in the cell.
CD spectra in the far-UV range were smoothed by using
the JASCO noise reduction routine. CD data are pre-
sented in units of molar ellipticity per residue.
Preparation of Samples for CD Spectroscopy
HsCen-2 or 25 HsCen-2 in 50 mM Tris, 1 mM Na
EDTA, 1 mM DTT, pH 7.4, were dialyzed extensively
against 10 mM MOPS, 1 mM EGTA (free acid), pH 7.4
or 60 mM MOPS, 100 mM KCl, 1 mM EGTA (with 35
mM Na added from pH adjustment) pH to 7.4 (pre-
pared using acid washed glassware) at 4 °C in a 10 0.5
ml microdialyzer, 1000 MWCO SpectraPor 6 dialysis
membrane (Spectrum Industries). Dialyzed protein was
given a microcentrifuge clean spin at 15,000  g for 6
min, and supernatant was placed in a new tube. The
protein was then diluted into buffer to give 0.1 mM
protein which was used for CD spectra measurements.
Secondary Structure Calculation
Secondary structure of HsCen-2 was calculated from
CD spectra in the far-UV spectral range using the
CDPro suite of programs [61]—a modified version of
three methods: SELCON3 [62], CONTIN/LL-CONTIN
method [63] in locally linearized approximation [64],
and CDSSTR [65]. In addition to the secondary struc-
ture content, programs in the CDPro package also
calculate the number and average length of the second-
ary structure segments. The number of secondary struc-
ture segments is calculated by dividing the number of
residues included in the distorted helical structure by
factor of four and in the distorted  structure by factor
of two. Dividing the total amount of residues in  helix
or  strand (ordered plus distorted) by the number of
segments gives the average length of the segment.Tertiary structure class was determined by the CLUSTER
program [66] of CDPro. Two sets of reference proteins
were used for secondary structure calculation: 48 pro-
teins [67], or 23    reference proteins, which were
selected by the CLUSTER program. The average value
of the six quantities (three methods and two reference
sets) RMS deviations are presented in Table 1.
Measurement of Protein Concentration
The spectrophotometric method was used for the con-
centration determination. Measurements in the
near-UV range were done using a DU 640 spectrometer
(Beckman) with a spectral bandwidth of 1.8 nm, and
employing the apo-centrin 2 M absorptivity of 1.46
mM1cm1 at 277 nm obtained by averaging the results
from four methods of calculation [68–71]. All spectra
were corrected for turbidity by plotting the dependence
of the log of the absorbance of the solution versus the
log of the wavelength and extrapolating the linear
dependence between these quantities in the range 340–
440 nm to the absorption range 240–300 nm. The
extrapolated values of absorbance were then subtracted
from the measured value. These corrections decreased
the apparent absorbance of protein at 277 nm by
about 15%. The scatter correction routine of the DU-640
was used for this purpose.
Results and Discussion
Figure 1 shows the alignment of the four known mam-
Table 1. Secondary structure of HsCen-2 in Apo-, Mg2-, and
Ca2-states at 0°C in buffer of high ionic strength (60 mM
MOPS, 100 mM KCl, 1 mM EGTA, 3 mM MgCl2 or CaCl2, pH
7.4) calculated from far-UV CD spectra on Figure 9.
Apo-state
Mg2-
saturated
state
Ca2-
saturated
state
regular 22.7  1.3 23.4  1.4 25.2  2.4
distorted 17.0  0.4 17.0  0.2 17.5  0.5
total 39.7  1.4 40.4  1.4 42.7  2.0
regular 4.5  3.2 5.2  2.5 5.5  1.7
distorted 5.9  0.3 5.8  0.2 5.3  0.9
total 10.4  3.5 11.0  2.6 10.8  0.9
turns 19.1  2.4 18.0  2.8 16.3  3.0
Unordered 30.7  2.5 30.8  1.9 30.0  0.6
N 7.5  0.2 7.5  0.1 7.7  0.2
L
av
9.4  0.3 9.5  0.3 9.8  0.7
N 5.3  0.4 5.2  0.2 4.5  0.7
L
av
3.4  0.9 3.7  0.7 3.6  0.8
regular or regular, fraction of residues (%) in central part of helical
segments or  strands; distorted or distorted, fraction of terminus
residues (%) in helices (two at each end of helix; four total per helical
segment) or  strands (one residue at each end of strand; two total per
strand); total or total, total content of  or  structure is equal to the
sum of the fractions (%) of regular and distorted residues; turns,
fraction of residues (%) in turns; Unordered, fraction of residues (%) in
unordered structure; N or N, number of helix or  strand, L
av
or L
av
,
average number of residues per helix (1.5 Å per residue) or  strand
(3.4 Å per residue).malian centrins. The EF-hand sequences representing
n.
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lighted in green. There is considerable sequence homol-
ogy among these members of the centrin family. The
EF-hand sequences show significant divergence,
through substitution of invariant amino acids from
canonical EF-hands except for site IV at the C-terminus
[19, 72–78]. Of note is the very basic N-terminus pre-
ceding the first EF-hand; this is the unique element in
centrin sequences relative to other EF-hand proteins.
Metal Ion Binding Studies
We showed previously that micro-flow electrospray
ionization-mass spectrometry (ESI-MS) can be used to
determine stoichiometries of ion binding to EF-hand
and zinc finger proteins and is useful for identifying
protein-small ligand, protein-protein and protein-DNA
interactions [23–40]. Relative affinities and stoichiome-
tries of metal binding determined by ESI-MS reflect
values defined in solution. We, therefore, undertook to
identify the metal ion binding stoichiometries for
HsCen-2 by ESI-MS.
Apo-HsCen-2 Exists in Two Conformations
Using ESI-MS in the positive-ion mode and 17 M
HsCen-2 in 25 mM ammonium acetate, we determined
Ca2 or Mg2 binding by preincubation of the protein
with metal ions of increasing concentration (0, 50, 100,
200, 300, 400 M). Figure 2 shows the ESI-MS spec-
trum of apo-HsCen-2 analyzed under optimal condi-
tions for native conformation detection. The inset in
Figure 2 shows the ESI-MS spectrum of apo-HsCen-2
analyzed under standard protein denaturing conditions
(water, acetonitrile, acid). This spectrum consists of one
charge state distribution of charge states 27 to 10
over them/z range of 700 to 2100. The calculated mass of
HsCen-2, from primary sequence information, is 20148
Da (see Materials and Methods). The ESI-MS mass
Figure 1. The amino acid sequence of human
EF-hands in human centrin-2 are highlighted in g
indicate homologous amino acids at that positio(Mr) under denatured and native conditions indicatesHsCen-2 in the apo-state is of the correct molecular
mass.
The presence of two charge state distributions noted
in Figure 2 demonstrates two distinct monomer confor-
mations of native HsCen-2. Monomer conformation 1 is
represented by a lower m/z range charge state distribu-
tion (20 to 10) while monomer conformation 2 is
represented by the 9 and 8 charge states. Both
conformations share charge states 10 and 9, how-
ever, deconvoluted spectra of the metal ion binding to
charge state 10 is more reflective of conformation 1
and charge state 9 more reflective of conformation 2.
To minimize the influence of shared charge state ions,
all metal binding results have been analyzed using the
rin-1-3 and mouse centrin-4. The four putative
. Asterisks indicate amino acid identities; period
Figure 2. Positive-ion ESI mass spectrum showing the multiply
charged ion series for 17 M HsCen-2 in 25 mM ammonium
acetate, pH 7.5. Two different monomeric (M) conformations are
attributed to the two charge-state distributions of m/z 1000–2100
(charge states 20 to 10) and m/z 2100–2700 (charge states 9
and 8). A dimeric (D) conformation charge state distribution is
also observed at m/z 2600 to 4100 (charge states 14 to 10). The
inset shows the multiply charged ion series for 20 M HsCen-2
under denaturing conditions (water, acetonitrile, acid) with onecent
reencharge state distribution (charge states 27 to 10).
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and the 8 charge state to represent monomer confor-
mation 2. Both of these charge states when transformed
give an average molecular mass (Mr) for HsCen-2 of
20,150 Da (expected value 20148 Da). Dimeric apo-
HsCen-2 and a minimal amount of trimeric apo-
HsCen-2 are also observed in Figure 2. The ions ob-
served atm/z 2880 and 3360 correspond to the monomer
charge states of 7 and 6 and to the dimer charge
states of 14 and 12 and therefore, were not used in
the analysis of the metal binding properties of the
monomer.
Apo-HsCen-2 Binds Ca2 in Both Conformational
States
In Figures 3, 4, 5, and 6 are shown transformed spectra
deconvoluted over each of the two charge-state ions,
14 and 8 representing conformation 1 and confor-
mation 2, respectively. Figure 3 shows data obtained
following the titration of 17 M apo-HsCen-2 with
increasing amounts of Ca2. The transformed mass
spectra of apo-HsCen-2 are shown in row A; with the
addition of 50 M Ca2 (3:1 M ratio), row B; and with
addition of 100 M Ca2 (6:1 M ratio), row C. A form
of HsCen-2 with one Ca2 bound to the protein is
detected in both conformations, in addition to a sub-
stantial amount of apo-HsCen-2. Some HsCen-2 con-
taining two Ca2 (Figure 3, row C) is detected in
conformation 2. A small amount of dimeric apo-
HsCen-2 and 1Ca2-dimeric HsCen-2 and 2Ca2-
dimeric HsCen-2 are also detected (data not shown).
With the addition of 200 M Ca2 (12:1 M ratio,
Figure 6, row A) conformation 1 is converted to more of
the HsCen-2 with one Ca2 relative to that seen at 100
M added Ca2, and has detectable 2Ca2-HsCen-2. In
conformation 2, however, for the first time, the HsCen-2
is mostly in the Ca2-bound form. In conformation 2,
the 1Ca2-HsCen-2 is detected as the most abundant
species with a significant amount of 2Ca2-HsCen-2,
and detectable 3Ca2-HsCen-2. On increasing the
amount of added Ca2 to 300 M (18:1 M ratio, Figure
3, row D), conformation 1 has more of both the HsCen-2
with one and two Ca2 and detectable 3Ca2-HsCen-2.
Conformation 2, (Figure 3, row D), however, clearly
has the majority of the protein in the Ca2-bound form.
Most HsCen-2 in conformation 2 appears to have either
one (most abundant) or two (next most abundant) Ca2
bound. A significant amount of 3Ca2-HsCen-2 is
present, and a 4Ca2 form of HsCen-2 is observed.
Detectable amounts of 5Ca2-HsCen-2 and 6Ca2-
HsCen-2 observed may be due to the addition of large
amounts of Ca2. On increasing the Ca2 addition to
400 M Ca2 (24:1 M ratio, data not shown) the
detectable amounts of the 1, 2 and 3-Ca2-forms of
conformation 1 HsCen-2 have modestly increased, and
a 4Ca2 form of HsCen-2 is detectable, although it is a
minor amount of the total. Conformation 2, by contrast,now exists as 2Ca2-HsCen-2 as the most abundant
single species, with 1Ca2-HsCen-2 only slightly less
abundant. Significant amounts of 3Ca2-HsCen-2 are
present for conformation 2, with 4Ca2-HsCen-2 easily
detected. Thus, HsCen-2 in conformation 2, loads with
Ca2more rapidly, and more completely, than HsCen-2
in conformation 1. The charge-state distribution of
conformations 1 and 2 in the ESI-MS untransformed
spectra (see Figure 2) were similar in the presence of
Figure 3. Positive-ion ESI transformed mass spectra of 17 M
HsCen-2 from the 14 charge state (Monomeric Conformation 1,
Panel 1) and the 8 charge state (Monomeric Conformation 2,
Panel 2) for a calcium metal ion titration; (a) apo-HsCen-2 with no
added metal ions. (b) HsCen-2 plus 50 M calcium. (c) HsCen-2
plus 100 M calcium. (d) HsCen-2 plus 300 M calcium.0–400 M Ca2 (data not shown).
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We similarly undertook titration of HsCen-2 (17 M) by
incubation of protein with Mg2 of increasing concentra-
tion (0, 50, 100, 200, 300, 400 M) to determine the Mg2
binding. Figure 4 shows titration of 17 M apo-HsCen-2
with increasing amounts of Mg2. In the transformed
spectra of HsCen-2 with the addition of 50 M Mg2
(3:1 M ratio, row A) and 100 M Mg2 (6:1 M ratio,
row B), a form of HsCen-2 containing one Mg2 is
Figure 4. Positive-ion ESI transformed mass spectra of 17 M
HsCen-2 from the 14 charge state (Monomeric Conformation 1,
Panel 1) and the 8 charge state (Monomeric Conformation 2,
Panel 2) for a magnesium metal ion titration; (a), HsCen-2 plus 50
M magnesium. (b) HsCen-2 plus 100 M magnesium. (c)
HsCen-2 plus 300 M magnesium.detected for both conformations, although it appearsmoreprominent for conformation 2.With 100MMg2most of
the HsCen-2 remains in the apo-form. Some 2Mg2-
HsCen-2 (Figure 4, row B) is detected for conformation 2.
A small amount of dimeric apo-HsCen-2 and dimeric
HsCen-2 with one and two Mg2 are also detected (data
not shown). Adding 200 MMg2 (12:1 M ratio, Figure
5, row A) resulted in increased amounts of the 1Mg2-
HsCen-2 and some 2Mg2-HsCen-2 in conformation 2.
With the addition of 300 MMg2 (18:1 M ratio, Figure
4, row C), conformation 1 of the protein shows increased
1 Mg2-HsCen-2 and some 2 Mg2-HsCen-2 (Figure 4,
row C). The amounts of 1 and 2 Mg2-HsCen-2 are less
than the apo-HsCen-2 in conformation 1. Conformation 2,
Figure 5. Competition between calcium and magnesium ion
uptake. Positive-ion ESI transformed mass spectra of HsCen-2
from the 14 charge state (Monomeric Conformation 1, Panel 1)
and the 8 charge state (Monomeric Conformation 2, Panel 2) for
a calcium titration into 17 MHsCen-2 preincubated with 200 M
magnesium; (a) HsCen-2 with magnesium. (b) HsCen-2 with
magnesium plus 100 M calcium. (c) HsCen-2 with magnesium
plus 300 M calcium.
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Mg2 bound. The 1 Mg2-HsCen-2 is the most abundant
species, followed by apo-HsCen-2, 2 Mg2-HsCen-2 and
some 3 Mg2-HsCen-2. Addition of 400 MMg2 (24:1
M ratio, data not shown) resulted in some addition of
Mg2, seen as the 1- and 2 Mg2-HsCen-2 forms of
conformation 1. For conformation 2, the 1- and 2 Mg2-
HsCen-2 are the most abundant species followed by
apo-HsCen-2 and 3Mg2-HsCen-2. Some 4Mg2-HsCen-2
is detected. Thus, aswith the Ca2 titrations, conformation
2 loads more readily with Mg2 and to a greater extent
than does conformation 1. In fact, up to 4 (and maybe 5
and 6) Mg2 are taken up at 400 MMg2, but one Mg2
Figure 6. Competition between calcium and magnesium ion
uptake. Positive-ion ESI transformed mass spectra of HsCen-2
from the 14 charge state (Monomeric Conformation 1, Panel 1)
and the 8 charge state (Monomeric Conformation 2, Panel 2) for
a magnesium titration into 17 MHsCen-2 preincubated with 200
M calcium; (a) HsCen-2 with calcium. b) HsCen-2 with calcium
plus 100 M magnesium. (c) HsCen-2 with calcium plus 300 M
magnesiumbinding site has, by far, the highest affinity, with a secondsite of significantly lower affinity. The third and fourth
Mg2 bound to HsCen-2 represent the lowest affinity
binding sites for Mg2 on the protein.
Competition Experiments
Competition experiments were then carried out by first
titrating increasing amounts of Ca2 into HsCen-2 pre-
incubated with 200 MMg2 followed by experiments in
which increasing amounts of Mg2 were titrated into
HsCen-2 preincubated with 200 M Ca2. The first metal
was incubated with protein for 30 min, and then for an
additional 30 min in the presence of the competing metal
before being analyzed by ESI-MS.
We first added increasing amounts of Ca2 to HsCen-2
preincubated with Mg2. Without Ca2 addition in the
presence of the 200 M Mg2, some 1Mg2-HsCen-2 is
detected for conformation 1. (Figure 5, row A). Conforma-
tion 2 (Figure 5, row A) exists with as much 1Mg2-
HsCen-2 as it does as apo-HsCen-2, a significant amount
of 2Mg2-HsCen-2, and detectable amounts of 3Mg2-
HsCen-2. With 50 M added Ca2 there is the obvious
observation of a peak representing 1Ca2-HsCen-2 for the
protein in conformation 1 (data not shown), without
diminution in the abundance of the 1Mg2-HsCen-2.
Similarly, for conformation 2 (data not shown), 50 M
Ca2gives a significant amount of 1Ca2-HsCen-2 with-
out diminution of the 1Mg2-HsCen-2. A peak also ap-
pears representing a 1Mg2/1Ca2-HsCen-2 species. Cal-
cium seems to be loading at a relatively Ca2-specific site,
a site different from that binding one Mg2. This is also
indicated by the observation of a peak representing
1Mg2/1Ca2-HsCen-2. On incubation with 100 M
Ca2, conformation 1 (Figure 5, row B) exists with some-
what less 1Mg2-HsCen-2 but the abundance of 1Ca2-
HsCen-2 remains similar, and the formation of some of the
1Ca2/1Mg2-HsCen-2 is seemingly at the expense of the
1Ca2-HsCen-2 form.
For conformation 2 (Figure 5, row B), addition of 100
M Ca2 produces somewhat less 1Mg2-HsCen-2 and
more 1Ca2-HsCen-2 and the mixed 1Mg2/1Ca2-
HsCen-2. On incubation with 200 M Ca2 (data not
shown), conformation 1 exists as comparable amounts of
1Mg2-HsCen-2 as at 100 M Ca2, but more 1Ca2-
HsCen-2 and 1Mg2/1Ca2-HsCen-2 forms. In addition,
some 2Ca2-HsCen-2 and 2Ca2/1Mg2-HsCen-2 are
present. Most of the apo- and 1Mg2-HsCen-2 of confor-
mation 2 are lost, and possibly the 1Ca2-HsCen-2 dimin-
ishes in favor of increasing amounts of 2Ca2-HsCen-2
and 1Mg2/1Ca2-HsCen-2; the 2Ca2-HsCen-2 becomes
the most abundant species along with 2 Ca2/1 Mg2-
HsCen-2 and significant amounts of 3Ca2-HsCen-2. For
the titration with 300 M Ca2, conformation 1 (Figure 5,
rowC) changes little from the 200MCa2 incubation but
for a slight increase in 2Ca2-HsCen-2 and possibly
2Ca2/1 Mg2-HsCen-2 and the appearance of detectable
amounts of 3Ca2-HsCen-2. Conformation 2 (Figure 5,
row C) also changes little from the 200 M Ca2 incuba-
tion but for the loss of more 1Mg2-HsCen-2 and 1Mg2/
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HsCen-2 and emerging amounts of 3Ca2/1Mg2-
HsCen-2 and 4Ca2-HsCen-2.
We next added increasing amounts of Mg2 to
HsCen-2 preincubated with Ca2. Without Mg2 addition
in the presence of the 200 M Ca2, some 1Ca2- and
2Ca2-HsCen-2 in conformation 1 are produced (Figure 6,
rowA). Conformation 2 (Figure 6, rowA) overall takes up
more Ca2 than does conformation 1, and exists more as
1Ca2-HsCen-2 as well as apo-HsCen-2 and a significant
amount of 2Ca2-HsCen-2 including detectable amounts
of 3Ca2- and 4Ca2-HsCen-2. With addition of 50 M
Mg2, conformation 1 (data not shown) is little changed
and Mg2 binding is unclear. Conformation 2 (data not
shown), however, clearly exists as small amounts of
1Mg2 HsCen-2 and 1Mg2/1Ca2-HsCen-2, and the
complexes seen before Mg2 addition are little changed.
Addition of 100 M Mg2 leaves conformation 1 (Figure
6, row B) only slightly changed, whereas for conformation
2 (Figure 6, row B), significant amounts of 1Mg2
HsCen-2, 1Ca2/1Mg2-HsCen-2 and 2Ca2/1Mg2-
HsCen-2 are now detected.
After addition of 200 M Mg2, conformation 1 (data
not shown) exists with the amounts of 1Ca2-HsCen-2
and 2Ca2-HsCen-2 relatively unchanged, but 1Mg2-
HsCen-2 and 1Ca2/1Mg2-HsCen-2 now appear. Con-
formation 2 with 200 M Mg2, (data not shown), in
contrast to conformation 1, has little apo-protein remain-
ing, and the amount of 1Mg2-HsCen-2 is increased.
1Ca2/1Mg2-HsCen-2 and 2Ca2/1Mg2-HsCen-2 now
increase while the peak height for 1Ca2-HsCen-2 de-
creases, suggesting it is converted to a complex also
containing oneMg2 or oneMg2 and one Ca2. Addition
of 300 MMg2 slightly increased the amounts of 1Mg2-
HsCen-2 and 1Mg2/1Ca2-HsCen-2 in conformation 1
(Figure 6, row C). The pattern of metal binding in confor-
mation 2 in the presence of 300 MMg2 is similar to that
observed to that with 200 M Mg2. Overall, Ca2 more
readily displaced Mg2, than Mg2 displaced Ca2, indi-
cating a greater affinity for Ca2 at those metal-binding
sites.
Binding of XPC Peptide to HsCen-2 and the Effect
of Ca2 on Complex Formation
Figure 7 shows the ESI-MS spectra of 52 M apo-
HsCen-2. In row A, monomeric (M) and dimeric protein
(D) are seen. In row B, adding XPC peptide to the
apo-HsCen-2 (6:1, peptide:HsCen-2) is seen to cause the
disappearance of dimeric HsCen-2 (D) and also a decrease
of charge states 9 and 8 compared to charge states 11
and 10. The spectra shows the appearance of the com-
plex of 1 XPC peptidewith onemolecule of HsCen-2 (M
XPC), or twomolecules of XPC peptide with onemolecule
of HsCen-2 (M  2XPC). The decrease in the amount of
the 9 and 8 charge states suggests the binding of the
peptide to monomer conformation 2. The disappearance
of the dimer may be due to instability of the complex as aresult of the large excess of peptide ions present. With
addition of Ca2 the profile is similar to that in Figure 7,
row B, with the Ca2-bound forms of HsCen-2 and both
single and double-molecule XPC bound to HsCen-2-Ca2
(data not shown); no dimeric HsCen-2 is observable. The
results change little for incubations extended up to 72 h
(data not shown).
Metal-Induced Change in HsCen-2 Conformation
Assessed by Mass Spectrometry
We previously demonstrated that monitoring gross pro-
tein secondary and tertiary structural changes upon metal
ion binding can be accomplished by ESI-MS. Changes in
charge state distributions upon Ca2 binding by calbindin
D28K and DREAM/calsenilin, and zinc binding by the
vitamin D receptor DNA binding domain, correlated with
changes in CD and fluorescence spectra (24, 25, 27-29, 32).
Calcium andmagnesium addition to apo-HsCen-2 did not
change the charge-state distributions upon metal binding,
indicating no gross change in protein conformation.
We next examined 25 HsCen-2 centrin because the
NH2 terminus is believed to play role in centrin self-
assembly when high concentrations of Ca2 and centrin
are present. By deleting the first 25 amino acids self
assembly is abolished. Using ESI-MS in the positive
mode and 17 M 25 HsCen-2 in 25 mM ammonium
Figure 7. Positive ion ESI mass spectra of the multiply charged
ion series of 52 M HsCen-2 incubated with XPC peptide for 30
min. (a) apo HsCen-2 with no added peptide or metal ions. (M,
monomer; D, dimer) (b) HsCen-2 plus 290 M XPC peptide. (M,
monomer; M  XPC, monomer plus XPC peptide)acetate, we determined the Ca2 and Mg2 binding by
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concentration (0, 50, 100, 200, 300, 400 M). The calculated
mass of this 25HsCen-2 construct, from primary se-
quence, is 17084Da (see Materials and Methods). The
ESI-MS mass (Mr) indicates all the 25HsCen-2 is in the
apo-state and of the correct mass (Figure 8). In general, the
metal-binding characteristics of 25 HsCen-2 are similar
to those of the full-length protein (data not shown).
CD Spectroscopy
Far- and near-UV CD spectra of HsCen-2 are shown in
Figure 9. The shape and amplitude of far-UV CD spectra
are characteristics of proteins with a high content of helical
structure. Only small changes in the far-UV spectra of
HsCen-2, as well as 25 HsCen-2 (data not shown) occur
in the presence of added calcium or magnesium. For
example, the molar ellipticity at 222 nm increases 6.1% in
theMg2-saturated and 11.8% in the Ca2-saturated states
in comparison to the apo-state. The isobestic point of all
three curves in Figure 9 is close to 203 nm. All these
changes in the far-UV CD spectra are consistent with an
increase in helical content of the protein upon bivalent
cation binding.
The near-UV CD spectra (Figure 9, insert) do not show
any signal from the only tyrosine residue (Tyr 172) in the
protein and instead show three negative signals at 255,
262, and 268 nm belonging to the 10 phenylalanines
(Phe) of HsCen-2. Differential near-UV CD spectra be-
tween cation-bound states and the apo-state (data not
shown) demonstrate the absence of changes in tertiary
structure upon Mg2-binding (apparent changes are due
to changes in amplitude of the far-UV CD background in
near-UV range). An analysis of the spectral changes with
Ca2-binding shows that an increase in asymmetry of
Figure 8. Positive ion ESI mass spectra of the multiply charged
ion series of 17 M 25HsCen-2 in 25 mM ammonium acetate, pH
7.5. Two different monomeric conformations are observed at m/z
1000–2000 (charge states 14 to 9) and m/z 2000–2500 (charge
states 8 and 7). The inset shows the transformed mass spec-
trum of the apo 25HsCen-2.microenvironments of Phe occurs (28% change overbackground), and this is indicative of changes in protein
tertiary structure.
Far- and near-UV CD spectra of the protein at 0 °C in
buffer of high or low ionic strength are similar (data not
shown). Table 1 shows results from the calculation of
secondary structure of HsCen-2 from the far-UV CD
spectra in Figure 1. Even though there are small increases
in the amplitude of the CD spectra, the secondary struc-
ture of HsCen-2 in the apo- or cation-bound states is
practically the same. The only significant difference (larger
than the RMS deviation) is an increase of 3  2% (5
residues) of the helical structure content upon Ca2 bind-
ing. Protein helical content is 43% (73 residues) in the
Ca2-saturated and40% in the apo-state (68 residues).
-sheet content is 11% (18–19 residues), -turns are
18% (28–32 residues), and unordered structure is 31%
(52–53 residues) for all states of the protein. Residues
included in helical structure form 7–8 segments with
average length of 9–10 residues (13–15 Å), and in the
-sheets, 4–5 strands have average lengths of 3–4 residues
(10-14 Å).
Cluster analysis of far-UV CD spectra [55] shows that
HsCen-2 belongs to the    tertiary structure class
proteins. Earlier reports presented similar conclusions
from CD measurements on HsCen-2 following Ca2 ad-
dition [19, 79, 80]. Durussel et al. showed that the protein
had a higher helix content (57% -helix 310 helix versus
43%, Table 1) and lower -sheet content (3% versus11%,
Table 1). They found a similar percentage of -turns (15%
turns versus18%, Table 1). The differences in amplitude
[80] and shape of the CD spectra and/or secondary
structure content [19] can be attributed to differences in
the protein concentration and/or differences in the meth-
ods by which secondary structure was calculated.
Figure 9. Far- and near-UV (insert) CD spectra of HsCen-2 in the
apo state (60 mMMOPS, 100 mMKCl, 1 mM EGTA, pH 7.4), in the
Mg2-saturated state (60 mM MOPS, 100 mM KCl, 1 mM EGTA,
3 mM MgCl2, pH 7.4), and in the Ca
2 saturated state (60 mM
MOPS, 100 mM KCl, 1 mM EGTA, 3 mM CaCl2, pH 7.4), at 0 °C.
[]MRW, molar (per mol of residues or mean residual weight)
ellipticity; Apo-state (solid line) , with addition of 3 mM Mg2(dashed line), with addition of 3 mM Ca2 (dash-dot-dot-dot line).
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the CD signal (upper panel) and the absorbance (lower
panel) at 222 nm are shown in Figure 10a for full-length
HsCen-2 in a low ionic strength buffer. These data show a
single broad temperature transition at 53 °C for apo-
HsCen-2, whereas two transitions are observed in the
Ca2-saturated state, one quite broad at 24 °C and
another at 77 °C with a higher degree of cooperativity.
The absorbance of both buffer and apo-protein gradually
increase with increased temperature, an expected “nor-
mal” temperature dependence. However, the Ca2-satu-
rated HsCen-2 shows an increase of turbidity in the
temperature range 10–30 °C from which we infer the
Figure 10. Temperature dependence of the first derivative of the
CD signal at 222 nm and absorbance at 222 nm of HsCen-2. (a)
Protein in buffer of low ionic strength ( 10 mM MOPS, 1 mM
EGTA, 3 mM CaCl2, pH 7.4). (b) 25 HsCen-2 truncated protein
(26-172 HsCen-2) in buffer of low ionic strength. (c) Protein in
buffer of high ionic strength (60 mM MOPS, 100 mM KCl, 1 mM
EGTA, 3 mM MgCl2 or CaCl2, pH 7.4); Apo-state (solid line),
with addition of 3 mMMg2 (dashed line), with addition of 3 mM
Ca2 (dash-dot-dot-dot line).formation of aggregates. Higher temperatures appear tolead to dissolution of these aggregates as the absorbance is
again close to that seen in apo-state. In Figure 10b are
shown the results of similar measurements for 25
HsCen-2. This truncated protein shows a single tempera-
ture transition in the apo-state just as with the full-length
protein, though at a lower temperature of 35 °C. Only
very minor differences are found for the Mg2-saturated
state. Whereas in the Ca2-saturated state of 25 HsCen-2,
two temperature transitions are again observed at26 °C
and 86 °C, slightly higher values than found for the
native protein. Also noted, no aggregation is observed
with 25 HsCen-2 in complex with Ca2 at any tempera-
ture examined. Figure 10c shows the effects of higher ionic
strength (100 mM KCl) buffer on native HsCen-2. The
mid-point temperature transition for the apo-state and the
higher-temperature transition of the Ca2-loaded state
were increased 3–4 °C. Interestingly, the mid-point of the
lower-temperature transition for the Ca2-loaded protein
increased by 23 °C compared to that seen in Figure 10a
(low ionic strength buffer). The more physiological ionic
strength also prevented the macroscopic aggregate forma-
tion seen without salt. The temperature dependence of
these CD and absorbance data in Figure 10 are 70–90%
reversible in repeated cycles after rapid cooling from 91 °C
back to 0 °C.
This is the first examination usingESI-MS of themetal
binding to HsCen-2. As shown in Figure 2 and Figure 8,
the ESI-MS spectra of both the HsCen-2 and 25
HsCen-2 show two charge-state distributions that respond
differently to added cations (Figures 3–6 for full-length
HsCen-2 and for 25 HsCen-2, those data are not shown).
The two charge-state distributions may represent the
following: conformation 1: A disordered state that when
electrosprayed, yields more charging due to exposure of
amino acid side chains, and less cation binding due to
disordered binding structures. Indeed, Prakash and Ma-
zumdar [81] showed that the higher charged states in
positive ion ESI-MS are a consequence of unfolding,
affording a greater number of surface basic groups. Dena-
tured calmodulin also sprays with higher charge states
than does the wild type [82]. Others suggest, however,
that the higher charged states correlate only with surface
area and not the number of exposed side chains [83].
Conformation 2: A folded, native state of the protein with
normally folded EF-hand sequences. A similar bimodal
charge-state distribution in 10 mM ammonium acetate
was described for an ESI-MS of calmodulin [82]. Never-
theless, HsCen-2 in conformation 2 continues to add
calcium until the apo-protein becomes a minor compo-
nent of the total. The highest and next highest affinity
calcium binding sites of the HsCen-2 took up most of the
Ca2, suggesting that intact EF-hands and intact protein
structure could account for the extensive calcium loading
of HsCen-2. Conformation 1, by contrast, loaded calcium
to a much lesser extent.
As shown in Figure 3, we found that HsCen-2 binds
one Ca2 with high affinity. We also found that the
protein has three low affinity Ca2-binding sites. We
know from studies of other proteins that the changes in
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and fluorescence [24, 25, 27–29, 32]. The binding of Ca2 to
HsCen-2 does not result in a significant change in the
charge state distribution of the protein, suggesting little
change in secondary structure, a finding confirmed by
far-UV spectroscopy (Figure 9 and Table 1). In addition, as
demonstrated in Figure 4, we found that HsCen-2 binds
one Mg2 with high affinity and three Mg2 with lower
affinity. Furthermore, our data demonstrate that the high
affinity Ca2-binding site is different than the high affinity
Mg2-binding site (Figures 5 and 6). The binding of Mg2
to HsCen-2 does not cause a significant change in the
charge state distribution of the electrospray protein, indi-
cating a lack of change in tertiary and secondary structure
that was confirmed in near- and far-UV spectroscopy
experiments (Figure 9 and Table 1).
We are able to demonstrate that Ca2 readily competes
for Mg2-binding sites in the Mg2-saturated protein. The
same is true of Mg2, which is capable of displacing Ca2
from the Ca2-saturated protein, although Ca2 appears
to be more efficient in displacing Mg2 than the opposite.
25 HsCen-2 has metal-binding properties that are similar
to those of full-length HsCen-2.
The binding of Ca2 and Mg2 to HsCen-2 appears to
be similar to that observed for DREAM/calsenilin [25],
but the binding is distinct from that of calbindin D28K [23]
which, from ESI-MS results, rapidly loads to give the
4Ca2-calbindin D28K form of the protein.
Our results are in contrast to those of Durussel et al.,
who observed by gel-filtration methods that HsCen-2
exists as a 1.5 Ca2/HsCen-2 dimer and 2 Ca2/HsCen-2
dimer, and by flow dialysis, a 4 Ca2/HsCen-2 dimer
complexed to two melittin peptides [19]. The high affinity
Ca2 binding site was likely site IV in each monomer [19].
Additional Ca2 binding sites were of low affinity. Other
centrins for which Ca2-binding was reported include
Chlamydomonas centrin, which binds four moles of cal-
cium/mol protein [22]. No data were previously reported
concerning the Mg2-binding stoichiometry of HsCen-2
or Chlamydomonas centrin other than to note that the
uptake of Mg2 reduces the affinity of calcium in both
proteins [19, 80].
Even though there are small increases in the amplitude
of the far-UV CD spectra (Figure 9), the secondary struc-
tures of HsCen-2 in apo-, Mg2- and Ca2-saturated states
turn out to be practically the same (Table 1). The only
difference is a 3 2% increase in total helicity upon Ca2-
but not Mg2-binding. This increase in helicity also has to
be attributed to folding of N-terminal domain upon Ca2
addition. The near-UV CD spectra do not show any signal
from the only Tyr 172 of HsCen-2; the sharp negative
bands in the spectral range 250–270 nm belong to the 10
phenylalanine residues. These results imply that the C-
terminus of HsCen-2 (side-chain of Tyr) is free and is not
fixed in the protein tertiary structure. The near-UV CD
spectra demonstrate that there are no changes in tertiary
structure upon Mg2-binding. Analysis of spectral
changes upon Ca2 binding shows changes in the asym-
metry of phenylalanine microenvironments and, there-fore, indicates some change in protein tertiary structure.
These changes in the near-UV CD spectra can also be
ascribed to the appearance of induced optical activity of
phenylalanine residues in the N-terminal domain when it
is stabilized and folded as a result of Ca2 addition.
Apo-HsCen-2, in a buffer with low ionic strength, has
one very broad temperature transition at 53 °C. In the
Ca2-saturated state it has two peaks at 24 (broad) and
77 °C (much sharper andmore cooperative than the first
one). An increase in temperature in the range 10–30 °C,
leads to reversible aggregation of protein in the Ca2-
loaded state. For the protein missing the N-terminal 25
residues and in a low ionic strength buffer, an increase of
buffer ionic strength does not cause aggregation of the
protein. Amore stable structural domain, with a midpoint
temperature of denaturation at 50–56 °C in the apo-
state, probably results fromdenaturation of the C-terminal
part of HsCen-2 [19], which is likely to have within it the
high affinity Ca2-binding site. On the basis of these data,
it is unlikely that apo-HsCen-2 would crystallize at0 °C,
because the N-terminal half of molecule would be disor-
dered at this temperature.
Small increases in the amplitude of the far- or near-UV
CD spectra upon Ca2-binding by HsCen-2 indicate small
changes in the secondary structure, and some change in
the tertiary structure of the protein. This can be attributed
to changes in protein stability (rigidity). One structural
and functional domain of HsCen-2 in the apo-state is
melted at 0 °C; a second one has the midpoint of heat
denaturation at 53 °C. The first domain is stabilized by
Ca2-binding and the midpoint of heat denaturation is
shifted to higher temperatures (24–47 °C). The midpoint
of heat denaturation for the second domain is shifted to
77–86 °C with an increase in cooperativity of denatur-
ation.
Overall, the far- and near-CD studies indicate little
Ca2- or Mg2-induced structural changes while the tem-
perature denaturation studies show Ca2-specific effects.
Other indications that there are no large structural
changes on metal binding include the lack of changes in
both the ESI charge-state distributions upon metal addi-
tion (Figure 2; see Results) and in nondenaturing poly-
acrylamide gels of apo-HsCen-2 when calcium or magne-
siumwas added in a 4:1 M ratio; no significant changes in
electrophoretic mobility of HsCen-2 occurred (data not
shown). In addition, in H/D exchange studies, the deute-
rium uptake of the apo-HsCen-2 is similar to that of holo
(20-fold excess Ca2) studied as a function of time, sug-
gesting that the conformational change of the protein
upon binding to Ca2 is small [84].
Conclusions
Our investigations have, for the first time, defined that
HsCen-2 binds one calciumwith relatively high affinity,
a second with significantly lower affinity and two more
with lower affinity yet. A similar pattern pertains for
Mg2 binding, although the binding sites for Ca2 are
relatively more specific. Removal of the N-terminal 25
1170 CRAIG ET AL. J Am Soc Mass Spectrom 2006, 17, 1158–1171residues affords a HsCen-2 that remains soluble even
after addition of Ca2. Increasing the ionic strength
does not induce full length HsCen-2 to assemble into an
aggregate insoluble complex upon addition of Ca2.
This lack of aggregation may promote efforts to crys-
tallize the Ca2-bound forms of HsCen-2. Addition of
Ca2, but not Mg2, to HsCen-2 stabilizes the protein.
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